Orexin (also known as hypocretin) neurons play a key role in regulating sleep-wake behavior, but the links between orexin neuron electrophysiology and function have not been explored. Orexin neurons are wake-active, and spiking activity in orexin neurons may anticipate transitions to wakefulness by several seconds. However, it is suggested that while the orexin system is necessary to maintain sustained wake bouts, orexin has little effect on brief wake bouts. In vitro experiments investigating the actions of orexin and dynorphin, a colocalized neuropeptide, on orexin neurons indicate that the dynamics of desensitization to dynorphin may represent a mechanism for modulating local network activity and resolving the apparent discrepancy between the onset of firing in orexin neurons and the onset of functional orexin effects. To investigate the role of dynorphin on orexin neuron activity, a Hodgkin-Huxley-type model orexin neuron was developed in which baseline electrophysiology, orexin/dynorphin action, and dynorphin desensitization were closely tied to experimental data. In this model framework, model orexin neuron responses to orexin/dynorphin action were calibrated by simulating the physiologic effects of static orexin and dynorphin bath application on orexin neurons. Then behavior in a small network of model orexin neurons was simulated with pure orexin, pure dynorphin, or combined orexin and dynorphin coupling based on the mechanisms established in the static case. It was found that the dynamics of desensitization to dynorphin can mediate a clear shift from a network in which firing is suppressed by dynorphin-mediated inhibition to a network of neurons with high firing rates sustained by orexin-mediated excitation. The findings suggest that dynamic interactions between orexin and dynorphin at transitions from sleep to wake may delay onset of functional orexin effects.
The orexin neuropeptides, orexins A and B (also known as hypocretins 1 and 2), play a well-established role in the regulation of sleep-wake behavior (Adamantidis et al. 2007; Brisbare-Roch et al. 2007; Lee et al. 2005; Mileykovskiy et al. 2005; Peyron et al. 1998; Sakurai et al. 1998) , and disrupted orexin signaling causes narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and dysregulation of behaviors associated with rapid eye movement (ReM) sleep (see (Dauvilliers et al. 2007; Scammell 2003) for review).
Recent experimental work has sought to characterize orexin neuron electrophysiology, including the response of orexin neurons to the neuropeptides orexin and dynorphin (eggermann et al. 2003; Li et al. 2002; Li and van den Pol 2006) . Double-label in situ hybridization showed that orexin neurons expressed both preproorexin mRNA and prodynorphin mRNA, and colocalization of these neuropeptides was confirmed through double-label immunohistochemistry (Chou et al. 2001) . Although it is unusual for colocalized peptides to exert opposite effects on postsynaptic targets (Hokfelt et al. 1986) , orexin is typically excitatory while dynorphin is generally inhibitory Li and van den Pol 2006; Liu et al. 2002; van den Pol et al. 2002) . However, depending on the postsynaptic population, orexin and dynorphin can work synergistically or competitively. In the tuberomammillary nucleus (TMN), orexin excites TMN neurons while dynorphin inhibits local interneurons for a net synergistic excitatory effect (eriksson et al. 2004 ). On the other hand, current evidence suggests that orexin and dynorphin exert competing effects on orexin neurons Li and van den Pol 2006) . These competing effects may provide a mechanism to mediate complex signaling both locally within the orexin field and, potentially, in distinct postsynaptic neuronal populations.
Furthermore, the dynamics of competing autoeffects may be crucial for understanding the role of orexin in sleep-wake regulation. Although extracellular recordings show that orexin neurons may begin firing several seconds before a transition into wakefulness (Lee et al. 2005; Mileykovskiy et al. 2005) , analysis of wake bout durations in wild-type and orexin knockout (OXKO) mice, a rodent model of narcolepsy, suggests that while orexin is important for sustaining long wake bouts, the production of brief (<2 min) wake bouts is not affected by the absence of orexin (Diniz Behn et al. 2008) . The possibility of a delay in orexinergic action is supported by the differential behavioral results observed when orexin neurons and locus coeruleus (LC) neurons are optogenetically stimulated during sleep: for both populations the probability of transition to wakefulness increases, but the immediacy of the effect is much more pronounced with LC neurons (Adamantidis et al. 2007; Carter et al. 2009 ). In prior work, we explored the implications of a delayed onset of functional, wake-promoting effects of orexin neurons in a mathematical model of the sleep-wake regulatory network, and we found that such a delay was essential for facilitating consolidation of sleep-wake behavior without altering the total amounts of time spent in each state (Diniz Behn et al. 2008) .
One possible explanation for the apparent delay in functional effects of orexin until 1 to 2 min after the onset of wake involves the interactions between colocalized orexin and dynorphin in orexin neurons (Chou et al. 2001) . Although these neuropeptides appear to generate competing autoeffects in orexin neurons, desensitization to one or both neuropeptides may modulate the net effect of peptide corelease. Interestingly, orexin neurons began to desensitize to dynorphin after approximately 90 sec, but no desensitization to orexin was found in these cells (Li and van den Pol 2006) . These data suggest that the dynamics of desensitization to dynorphin may modulate the wake-promoting effects of orexin neurons, thereby resolving the apparent temporal conflict between orexin neuron activity onset and wake-promoting action.
Theoretical frameworks allow detailed investigation of dynamics that can be difficult to address in an experimental setting. Therefore, to investigate the role of dynorphin in the wake-promoting effects of orexin neurons, we developed a Hodgkin-Huxley-type model orexin neuron, simulated the physiologic effects of orexin and dynorphin, and analyzed the effects of dynorphin desensitization on small networks of model orexin neurons.
MATERIALS AND METHODS

Single-Cell Model
We modeled orexin neurons using a standard Hodgkin-Huxley model formalism. The equation for the change in membrane potential, dv/dt, in summed current notation, is given by
where C is the capacitance of the cell membrane, I 0 is an applied current (set to zero for baseline model orexin neuron behavior), E noise represents stochastic input to the system, and I j for j = {Na, K, K2, T, h, CAN, Cal, L, GIRK} are intrinsic currents. The presence of these currents in orexin neurons has been suggested by experimental work (eggermann et al. 2003; Li et al. 2002; Li and van den Pol 2006) , but, to our knowledge, orexin neuronspecific characterization of these intrinsic currents has not been published. Therefore, we initially constructed model currents based on formalisms that have been published for other cell types (Buchholtz et al. 1992; Destexhe et al. 1994) , and, if necessary, we refined each current formalism subject to the constraints of reported properties of orexin neuron electrophysiology as described in the supplementary online material. Briefly, the current formalisms we implemented included the following: standard spiking sodium and potassium currents I Na (v) = g Na ⋅ m 3 ⋅ h ⋅ (v -v Na ) and
Since some variables and parameters in the neuron current balance equation are calcium-dependent, we explicitly modeled intracellular calcium concentration, [Ca 2+ ] following the approach of Buchholtz and colleagues (Buchholtz et al. 1992) .
The full sets of gating variable equations and parameter values, as well as the details of calcium modeling, are presented in the supplementary online material. To evaluate the sensitivity of model behavior to model parameters, we conducted a sensitivity analysis in which each parameter was varied by ±5%.
Stochastic Synaptic Input
To observe the model neuron's response to physiologic noise, we simulated random postsynaptic currents (PSCs) acting on the model neuron. PSCs in orexin neurons have been well-characterized, so the properties of simulated PSCs, including excitatory/inhibitory effect, amplitude, and rate, were constrained by experimental data . The model PSCs were Poisson in time and occurred at a rate rt = 4.3 Hz; PSC amplitudes were normally distributed with a mean of 15 pA and a standard deviation of 20 pA. These parameters resulted in mostly excitatory PSCs consistent with experimental reports (Li and van den Pol 2006) .
Simulating Depolarization and Hyperpolarization Protocols
To investigate the electrophysiological properties of the model orexin neuron, we simulated the depolarization and hyperpolarization protocols used to characterize orexin neurons experimentally: a depolarizing current step, depolarization from a hyperpolarized state, and hyperpolarizing current steps (eggermann et al. 2003) . We chose the magnitudes of our applied currents heuristically based on the response of the model orexin neuron.
Simulating Bath Application of Orexin and Dynorphin
We simulated the bath application of orexin and dynorphin by explicitly modeling their mechanisms of action. earlier experimental work indicated that orexin indirectly excites orexin neurons by exciting local glutamatergic neurons which, in turn, increase the frequency of ePSCs onto orexin neurons Li and van den Pol 2006) . Dynorphin acts through several direct and indirect mechanisms including decreasing the frequency of ePSCs, decreasing the strength of the low-threshold calcium current, and activating a GIRK current (Li and van den Pol 2006) . Recent results suggest that orexin may directly activate orexin neurons (Yamanaka et al. 2010) . However, since we focus on the orexin and dynorphin results of Li and van den Pol (2006) , we will restrict our consideration to the indirect actions of orexin on orexin neurons.
We mimicked these mechanisms in our model. Modulation of the frequency of (mostly excitatory) PSCs was achieved by adding the terms ox noise ⋅ ox(t) and dyn noise ⋅ dyn(t) to increase/decrease the parameter controlling the rate of PSCs, rt. For orexin effects, we focused on the action of orexin A: we set the parameter ox noise = 0.0062 to reflect the 255% increase above baseline of PSC frequency in the presence of orexin A; although an increase in PSC frequency was also observed with application of orexin B, it was not as extreme . We set the parameter dyn noise = -0.0018 to reflect the decrease to 60% of baseline PSC frequency in the presence of dynorphin (Li and van den Pol 2006) .
We modeled direct dynorphin-mediated effects on I T and I GIRK by adding the terms dyn GIRK ⋅ dyn(t) and dyn T ⋅ dyn(t) to the maximal conductances associated with the appropriate currents:
, respectively. The value of dyn T = -0.3 was chosen so that dynorphin decreased the calcium current by approximately 28%, consistent with experimental reports (Li and van den Pol 2006) . The strength of dyn GIRK = 0.8 was determined by the strength necessary to achieve the dynorphin-mediated effect given the specified values of dyn noise and dyn T . Note that although this implementation captures the reported effects of dynorphin on I GIRK and I T , it is not meant to reflect a specific physiological mechanism by which these effects are achieved.
The step functions ox(t) and dyn(t) multiplied parameters ox noise and dyn j for j = {noise, T, and GIRK}, respectively. These functions controlled the onset and termination of bath application of orexin and dynorphin. To assess dose-dependent peptide bath application effects, we uniformly scaled the associated parameters. Li and van den Pol (2006) observed that orexin neurons desensitize to dynorphin more quickly than to orexin, so those investigators examined the effects of repeated coapplication. To simulate the successive coapplication protocol, we introduced a parameter, d2o, to scale dynorphin effects, dyn j for j = {noise, T, and GIRK}. Varying d2o from 1 to 0 uniformly reduced the dynorphin effects, consistent with desensitization to dynorphin. For the successive coapplication simulations, d2o = 1 for the initial application, and d2o = 0.5 and 0.25 for the second and third successive coapplications, respectively.
Small Network Model
To translate the mechanisms identified for bath application of orexin and dynorphin into dynamic network effects, we simulated a 2-cell network of orexin neurons with pure orexin coupling, pure dynorphin coupling, and colocalized orexin/dynorphin coupling. We modeled bidirectional coupling in the network by replacing the step functions ox(t) and dyn(t) with variables s i ox and s i dyn (i = 1,2) in each postsynaptic neuron. When the presynaptic neuron i spiked, s i ox and s i dyn (acting on the postsynaptic neuron) were initialized to 1. Following the spike, the variables decayed exponentially according to the time constants t ox and t dyn , respectively. Thus, the synaptic variables and bath application step functions activated the same direct and indirect mechanisms, but the synaptic variables introduced additional time dynamics reflecting dynamics in the synaptic cleft and in the opening and closing of ion channels. The appropriate range for such decay has been shown to span time scales from milliseconds to seconds (Destexhe and Sejnowski 2001) . Since experimentally determined values of these time constants have not been reported for orexin and dynorphin, we evaluated network behavior over a range of values for t ox and t dyn spanning 6 orders of magnitude (0.03-30 000 for t ox and 0.05-50 000 for t dyn ). Since both orexin and dynorphin act through G-proteincoupled metabotropic receptors and therefore act more slowly than neurotransmitters acting through ionotropic receptors, we chose default values of t ox and t dyn on the order of hundreds of milliseconds (t ox = 300 msec and t dyn = 500 msec) consistent with experimental data and modeling approaches for these and other neuropeptides (Destexhe and Sejnowski 2001; Postnova et al. 2009 ).
To simulate dynamic desensitization to dynorphin effects, we converted the parameter d2o to a variable with an initial condition of 1 and the following decay dynamics:
The parameters 15 000 msec and 0.25 were chosen, so d2o decayed to 0 over the course of a 30-sec simulation. Within each model neuron, the variable d2o scaled the dynorphin effects, so the magnitude of these effects decayed over time. To reveal the impact of a decaying d2o variable, we computed the average interspike interval for each second of data and performed a leastsquares linear fit.
Simulations were performed using the ordinary differential equation solver XPPAUT, developed by G. B. ermentrout and available at ftp://ftp.math.pitt .edu/pub/bardware. An adaptive stiff integration method with step size 0.01 was used for all simulations. Simulation output was analyzed using code written in MATLAB (The Mathworks Inc., Natick, MA).
RESULTS
To investigate the role of dynamics in the orexin neuron's responses to orexin and dynorphin, we developed a Hodgkin-Huxley-type model of an orexin neuron. After calibrating the baseline behavior of the model, we simulated its response to depolarization/ hyperpolarization protocols and bath application of orexin and dynorphin applied individually and together. Finally, we applied the modeling framework to simulate dynorphin desensitization in a 2-cell network coupled through orexin-and dynorphin-mediated synaptic effects.
Baseline Behavior in the Single-Cell Model
Baseline behavior in the model neuron was consistent with experimentally characterized electrophysiology. In the deterministic system, when stochastic input was omitted from the model, the neuron spiked spontaneously at a rate of 1 to 2 Hz, consistent with experimental data (eggermann et al. 2003; Li et al. 2002) ( Figure 1 ). The mechanism for spontaneous firing at a low frequency involved a subthreshold oscillation that grew in amplitude until the membrane potential reached the spiking threshold. By assessing the behavior of each current during the interspike interval and evaluating parameter sensitivities, we established that this subthreshold oscillation was a result of interactions between the depolarizing I CAN and the hyperpolarizing I K2 . With the addition of stochastic PSCs, the baseline spiking rate increased to 3 to 4 Hz, and the subthreshold oscillation was rarely observed (Figure 2A ). To simulate TTX application, we blocked the sodium current, I Na , (i.e., we set g Na = 0) and obtained a resting membrane potential ~ -57 mV, consistent with recordings from orexin neurons ) (data not shown). The currents I CAN and I Cal were essential for maintaining this depolarized resting membrane potential.
Our sensitivity analysis showed that this baseline behavior was largely preserved as parameters were varied. However, the model was sensitive to parameters associated with I K2 . By increasing the strength of I K2 , we could eliminate the subthreshold oscillations, but we also eliminated intrinsic spiking in the neuron. On the other hand, decreasing the strength of I K2 could cause significant increases in intrinsic spiking frequency. These results highlight the importance of I K2 for the robust, low-frequency spiking behavior in the model orexin neuron.
To establish consistent behavior between the model orexin neuron and experimental characterizations of orexin neuron electrophysiology, we simulated several depolarization/hyperpolarization protocols (eggermann et al. 2003) . When depolarized from rest, the model neuron tonically fired ( Figure 2B ), consistent with experimental data . The firing rate increased with the strength of the depolarizing pulse, but the amplitude of the spikes was decreased (data not shown). The maximum firing rate for the model orexin neuron was ~100 Hz. This maximum rate is lower than that observed in experiments and does not permit burst firing, a behavior that has been observed in orexin neurons during phasic ReM sleep (Mileykovskiy et al. 2005) . When a depolarizing current pulse was delivered while the model neuron was tonically hyperpolarized, the model neuron responded with a low-threshold calcium spike followed by a slow after-depolarization (Fig. 2C) . In response to hyperpolarizing current pulses, the model neuron displayed a membrane rectification characterized by a sag resulting from activation of I h ; following release from hyperpolarization, the model orexin neuron showed a rebound spike followed by a small after depolarization ( Figure 2D ). These responses show that the currents comprising the model orexin neuron capture salient features of orexin neuron electrophysiology.
Simulating Bath Application of Orexin and Dynorphin
We simulated bath application of orexin and dynorphin according to experimentally reported indirect and direct mechanisms (see Methods for details) Li and van den Pol 2006) . Orexin and dynorphin increased and decreased, respectively, the firing rate of the model orexin neuron consistent with experimental results (Figure 3A, B) . These effects were dosedependent ( Figure 3C, D) . . (B) . Magnifying the resting membrane potential in the 100 msec preceding a spike shows that the mechanism associated with this intrinsic spiking involves a subthreshold oscillation. The subthreshold oscillation increases in amplitude until the spiking threshold for the neuron is reached, and the neuron fires an action potential.
We also simulated successive coapplication of these neuropeptides when desensitization to dynorphin plays a role in neuronal response. Our initial coapplication showed a decrease in firing rate similar to that observed with pure dynorphin bath application (Figure 3e ). Subsequent coapplications of orexin and dynorphin elicited an increase in firing rates similar to pure orexin bath application ( Figure 3F ). These changes in the model neuron response to coapplication of orexin and dynorphin were consistent with the effects of repeated coapplication of these neuropeptides (Li and van den Pol 2006) .
Small Network with Orexin/Dynorphin Coupling
In the 2-cell network, we coupled model orexin neurons together using pure orexin coupling, pure dynorphin coupling, and colocalized orexin/dynorphin coupling with dynamic desensitization to dynorphin. With pure orexin coupling, the general increase in the rate of ePSCs led to an increase in firing rate ( Figure 4A ) and subthreshold oscillations were rarely observed ( Figure 4B ). Increasing the time constant associated with synaptic decay of orexin (t OX ), and hence the persistence of the orexin-mediated indirect excitation, caused a monotonic increase in spike frequency (Figure 4e) .
By contrast, for sufficiently large dynorphin time constants, dynorphinmediated synaptic coupling decreased spike frequency, and subthreshold oscillations were visible (Figure 4C, D) . In addition to the decreased rate of ePSCs, the direct inhibitory effects resulting from the activation of a GIRK current and a decrease in the strength of I T hyperpolarized the membrane potential of the postsynaptic neuron and contributed to slowing the firing rate. In contrast to bath application, the strength of synaptic dynorphin effects is modulated in time. Interestingly, the inhibitory effect of dynorphin was limited to parameter regimes in which the synaptic time constant t DYN was sufficiently long ( Figure 4F ). When t DYN was small (0.5-5 msec), pure dynorphin coupling actually resulted in a significant increase in firing activity. We hypothesize that this increase in spiking frequency is linked to the intrinsic dynamic structure of the model orexin neuron (see Discussion).
Finally, we modeled orexin and dynorphin corelease with dynamic desensitization to dynorphin. Dynamic desensitization resulted in a smooth shift from network behavior reflecting dynorphin-mediated inhibition to that associated with orexin-mediated excitation as tracked by a steady decrease in interspike interval ( Figure 4G ). This shift was qualitatively similar to the changes observed with successive coapplication in the bath application simulations.
DISCUSSION
We developed a Hodgkin-Huxley-type model of an orexin neuron and investigated the dynamics of action of orexin and dynorphin in this model in the context of both bath application and synaptic coupling. The physiological basis of our implementations has established a novel framework for analyzing orexin neuron -120, -135, -150, -165 nA) , the model orexin neuron demonstrates an h-current-related sag. In panels B-D, depolarization/hyperpolarization protocols are shown on lower axes with normalized units.
electrophysiology and the role of dynamics in the response of orexin neurons to orexin and dynorphin. Furthermore, this work has generated experimentally testable hypotheses to complement and inform experimental approaches.
Advantages and Limitations of the Proposed Model Orexin Neuron
The construction of the model orexin neuron was based as closely as possible on experimental data. each current included in the model was either experimentally identified or specifically indicated by experimental characterization of orexin neuron electrophysiology. The dynamic interactions of these currents produced a model neuron with electrophysiologic features that were consistent with key baseline behavior of orexin neurons and orexin neuron responses to various depolarization and hyperpolarization protocols. Furthermore, when orexin and dynorphin bath application were simulated according to experimentally identified mechanisms, the model orexin neuron showed appropriate, dosedependent responses. The detailed physiological model was important for the appropriate implementation of these mechanisms, and these results suggest that the model orexin neuron offers a useful theoretical framework for investigating the dynamics of action of these neuropeptides.
However, there are several important limitations to this approach. The most significant limitation is the singlecompartment Hodgkin-Huxley-type formalism. Although this modeling formalism has been very successful in describing neuronal activity, the data necessary to constrain the implementation specifically to orexin neurons are not available. Therefore, important currents may be missing; certain features of orexin neurons, such as the plateau potential on top of which spikes occur, may require additional model complexity; and the current formalisms employed in the model orexin neuron, adapted from different cell types, may not reflect orexin neuron-specific parameters. For example, the handling of calcium has been based on a standard modeling approach of calcium dynamics in a stomatogastric ganglion neuron (Buchholtz et al. 1992 ) and does not account for features, such as nonlinearities in calcium concentration rectification, that may be important for orexin neuron-specific calcium handling. This is a key direction for future work since different handling of calcium could strongly affect the putative role of calcium concentration-dependent currents in the model. Limitations regarding currents and current characterizations should be taken into account in the interpretation of predicted mechanisms underlying specific behaviors. For example, we found that the interaction between I CAN and I K2 gives rise to a subthreshold oscillation that is a key element for generating slow intrinsic spiking in the model orexin neuron. Although subthreshold oscillations in experimental recordings from orexin neurons have not been reported, our results suggest they may not be commonly observed under baseline experimental conditions since they require sufficiently long interspike intervals. Furthermore, since I CAN may participate in orexin-induced activation of orexin neurons (Yamanaka et al. 2010) , the interaction between I CAN and I K2 may be modified in the presence of orexin. However, the appearance of subthreshold oscillations may be an artifact of the implementation of these currents or the omission of another important current, and additional experimental work to characterize intrinsic currents in orexin neurons is necessary to further constrain the model orexin neuron and its dynamic structure.
Concentration of dynorphin
We have assumed electrophysiological homogeneity of orexin neurons. Although this assumption is consistent with early reports (eggermann et al. 2003; Li et al. 2002) , recent work has suggested that there may be different types of orexin neurons (Williams et al. 2008 ). Such differences could cause differential neuronal responses and may have important implications for local network activity in the orexin neuron field. Future work could explore these differences by appropriately varying relevant parameters in the model, thereby examining the impact of heterogeneity on local network behavior.
Finally, this approach is limited by the lack of experimental data pertaining to orexin and dynorphin release. Although the colocalization of these neuropeptides in orexin neurons has been established, the details of orexin and dynorphin release, including kinetics and diffusion distance, have not been characterized in these cells. Neuropeptide release may require the cell to fire above a threshold frequency or with a particular spiking pattern such as bursting (Brown and Bourque 2004; Whim and Lloyd 1989) . Furthermore, when neuropeptides are colocalized, the relative concentrations of expressed neuropeptides may shift as a function of firing rate or firing pattern (Bartfai 1985) . The degradation of neuropeptides can also affect their action: in other cell types, dynorphin has been shown to be an autocrine modulator that degrades quickly and does not diffuse far (Brown and Bourque 2004; Roper et al. 2004) . Additional work to determine the dynamics of orexin and dynorphin release and degradation will provide important physiological constraints on their possible interactions.
Predictions from Small-Network Simulations
By coupling model orexin neurons into a small network, we have developed a framework for analyzing local network interactions mediated by orexin, dynorphin, or colocalized orexin and dynorphin. Despite the simplicity of the 2-cell network structure, we identified several important features of network behavior under these different coupling conditions. As in the bath application case, pure orexin coupling increased firing rates with the percentage increase positively correlated with the synaptic time constant t OX . We anticipate that incorporating a direct orexin-induced activation of orexin neurons (Yamanaka et al. 2010) will enhance this effect, though this should be verified in future work.
By contrast, pure dynorphin coupling could decrease or increase firing rates compared to baseline, depending on the synaptic time constant t DYN despite the exclusive decrease in firing rates observed with dynorphin bath application. Since single-cell firing rates stayed above 1 Hz, large synaptic time constants resulted in a baseline level of ongoing dynorphin-mediated inhibition across the network. We hypothesize that the increase in spiking frequency observed with small t DYN is linked to the intrinsic dynamic structure of the model orexin neuron. For small t DYN , the hyperpolarization induced by dynorphin-mediated changes in I T and I GIRK would exert only a brief inhibitory effect. However, if the membrane potential of the postsynaptic neuron was in the appropriate regime, this brief hyperpolarization could trigger a subthreshold oscillation. The subthreshold oscillation brings the membrane potential to its spiking threshold, so this represents a mechanism whereby dynorphin-mediated inhibition could increase network activity. Since dynorphin acts through G-protein-coupled receptors, the physiologically appropriate synaptic time constant is probably large. However, these simulations show that network behavior depends on the kinetics of orexin and dynorphin release and degradation and suggest that experimental studies to establish these kinetics and other details of orexin and dynorphin release are essential for understanding local network activity.
Another network-related consideration in simulating activity of orexin neurons is the effect of statedependent interactions with other cell types. Within the lateral hypothalamus there are melanin-concentrating hormone (MCH) neurons and local glutamatergic neurons in addition to orexin neurons. Local glutamatergic neurons clearly play a role in mediating orexinergic effects on orexin neurons, but this role may be modulated by behavioral state or sleep homeostasis (Postnova et al. 2009; Rainnie et al. 1994) . MCH neurons are generally inhibitory to other neurons in the lateral hypothalamus , including orexin neurons (Rao et al. 2008) , and they are primarily active during ReM sleep (Modirrousta et al. 2005; Verret et al. 2003) . In addition to these local interactions, orexin and MCH neurons receive inputs from hypothalamic and brainstem regions involved in sleep-wake regulation which could modulate state-dependent properties of neurons and the local network (Yoshida et al. 2006) . Future modeling work could address the implications of specific state-dependent projections on activity in the local orexin field.
Role of Dynorphin Desensitization and Implications for the Role of Orexin Neurons in Sleep-Wake Regulation
The physiological action of dynorphin is mediated by kappa opioid receptors. Continuous exposure to dynorphin may reduce the affinity of the receptor, without affecting the density of kappa receptors, leading to dynorphin desensitization (Raynor et al. 1994) . To simulate this desensitization in the model, a parameter (single cell) or variable (small network) was used to scale dynorphin effects mediated through decreased frequency of ePSCs, decreased low-threshold calcium current amplitude, and activation of a GIRK current. In the single cell, this scaling allowed accurate simulation of the successive coapplication protocol. In the small network, the dynamics of desensitization to dynorphin mediated a clear shift from a network in which firing is suppressed by dynorphinmediated inhibition to a network in which orexin-mediated excitation sustains high firing rates.
Although the effect of these competing neurotransmitters on the local lateral hypothalamic network may be sufficient to delay the onset of functional orexin effects, the competing effects of orexin and dynorphin in the local orexin field may be amplified by similar competing effects in other postsynaptic wake-promoting populations. There is evidence that orexin and dynorphin exert a synergistic effect on some postsynaptic populations (eriksson et al. 2004 ) while exerting competing effects on others (eggermann et al. 2003; Li and van den Pol 2006; van den Pol et al. 2004) . Overall, the combined mechanisms of colocalization of orexin and dynorphin and desensitization to dynorphin provide a plausible explanation of a delayed onset in the functional role of orexin.
We and others have hypothesized that orexin neurons help stabilize states of wake and sleep behavior by acting on the sleep-wake switch, a key mechanism in behavioral state regulation (Diniz Behn et al. 2008; Mochizuki et al. 2004; Saper et al. 2005) . Although both experimental and modeling approaches have supported such a role for orexin neurons in sustained wake bouts (Adamantidis et al. 2007; Diniz Behn et al. 2008; Mochizuki et al. 2004) , the apparent absence of functional orexin effects during brief wake bouts has not been explained. Our findings suggest that interactions between coreleased orexin and dynorphin, mediated by the time scale of dynorphin desensitization, may account for the delay between the onset of activity in orexin neurons at transitions from sleep to wake and observed functional orexin effects, and they highlight the need for detailed experimental investigation of the kinetics of orexin and dynorphin release and degradation.
